Impact of COVID-19 on Male Urogenital Health: Success of Vaccines

Overview

Journal Drug Discov Today

Specialty Pharmacology

Date 2022 Jul 29

PMID 35905935

Authors

Kutay Kucukyildiz

Didem Yilmaz-Oral

Damla Turkcan

Cetin Volkan Oztekin

Serap Gur

Affiliations

Soon will be listed here.

Abstract

Throughout 2021, the scientific and medical communities were concentrated on dealing with the acute morbidity and mortality induced by the COVID-19 pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We reviewed the present data for adverse effects of COVID-19 on the different parts of the male urogenital system during the dynamic situation of the COVID-19 pandemic. With the approval of COVID-19 vaccinations, there is a ray of hope at the end of this dark tunnel and a chance to look ahead for the management of long-term consequences in males with urogenital illness. A multidisciplinary investigation of these cases could provide information for establishing and optimizing treatment protocols.

References

Song H, Seddighzadeh B, Cooperberg M, Huang F . Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells. Eur Urol. 2020; 78(2):296-298. PMC: 7200365. DOI: 10.1016/j.eururo.2020.04.065. View

Gonzalez D, Nassau D, Khodamoradi K, Ibrahim E, Blachman-Braun R, Ory J . Sperm Parameters Before and After COVID-19 mRNA Vaccination. JAMA. 2021; 326(3):273-274. PMC: 8293015. DOI: 10.1001/jama.2021.9976. View

Guo L, Zhao S, Li W, Wang Y, Li L, Jiang S . Absence of SARS-CoV-2 in semen of a COVID-19 patient cohort. Andrology. 2020; 9(1):42-47. PMC: 7362062. DOI: 10.1111/andr.12848. View

Apaydin T, Sahin B, Dashdamirova S, Yazan C, Elbasan O, Ilgin C . The association of free testosterone levels with coronavirus disease 2019. Andrology. 2022; 10(6):1038-1046. DOI: 10.1111/andr.13152. View

Nabeeh H, Ibrahim A, Taha D, Talaat M, Abdelbaky T . Impact of COVID-19 pandemic on lower urinary tract symptoms in patients with benign prostatic hyperplasia and predictors of urine retention in such patients. Low Urin Tract Symptoms. 2021; 14(1):41-46. PMC: 8661677. DOI: 10.1111/luts.12407. View

Verratti V, Di Giulio C, Berardinelli F, Pellicciotta M, Di Francesco S, Iantorno R . The role of hypoxia in erectile dysfunction mechanisms. Int J Impot Res. 2007; 19(5):496-500. DOI: 10.1038/sj.ijir.3901560. View

Paoli D, Pallotti F, Colangelo S, Basilico F, Mazzuti L, Turriziani O . Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab. J Endocrinol Invest. 2020; 43(12):1819-1822. PMC: 7179792. DOI: 10.1007/s40618-020-01261-1. View

Homa S, Vassiliou A, Stone J, Killeen A, Dawkins A, Xie J . A Comparison Between Two Assays for Measuring Seminal Oxidative Stress and their Relationship with Sperm DNA Fragmentation and Semen Parameters. Genes (Basel). 2019; 10(3). PMC: 6471935. DOI: 10.3390/genes10030236. View

Anifandis G, Messini C, Daponte A, Messinis I . COVID-19 and fertility: a virtual reality. Reprod Biomed Online. 2020; 41(2):157-159. PMC: 7206439. DOI: 10.1016/j.rbmo.2020.05.001. View

10.

Chen T, Bhambhvani H, Kasman A, Eisenberg M . The Association of the COVID-19 Pandemic on Male Sexual Function in the United States: A Survey Study of Male Cannabis Users. Sex Med. 2021; 9(3):100340. PMC: 8240149. DOI: 10.1016/j.esxm.2021.100340. View

11.

Nassau D, Best J, Kresch E, Gonzalez D, Khodamoradi K, Ramasamy R . Impact of the SARS-CoV-2 virus on male reproductive health. BJU Int. 2021; 129(2):143-150. PMC: 8444635. DOI: 10.1111/bju.15573. View

12.

Pradhan A, Olsson P . Sex differences in severity and mortality from COVID-19: are males more vulnerable?. Biol Sex Differ. 2020; 11(1):53. PMC: 7498997. DOI: 10.1186/s13293-020-00330-7. View

13.

Pizzol D, Shin J, Trott M, Ilie P, Ippoliti S, Carrie A . Social environmental impact of COVID-19 and erectile dysfunction: an explorative review. J Endocrinol Invest. 2021; 45(3):483-487. PMC: 8461150. DOI: 10.1007/s40618-021-01679-1. View

14.

Welen K, Rosendal E, Gisslen M, Lenman A, Freyhult E, Fonseca-Rodriguez O . A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022; 81(3):285-293. PMC: 8673828. DOI: 10.1016/j.eururo.2021.12.013. View

15.

Banihani S . Human semen quality as affected by SARS-CoV-2 infection: An up-to-date review. Andrologia. 2021; 54(2):e14295. PMC: 8646253. DOI: 10.1111/and.14295. View

16.

Lamb L, Dhar N, Timar R, Wills M, Dhar S, Chancellor M . COVID-19 inflammation results in urine cytokine elevation and causes COVID-19 associated cystitis (CAC). Med Hypotheses. 2020; 145:110375. PMC: 7644255. DOI: 10.1016/j.mehy.2020.110375. View

17.

Albersen M, Shindel A, Mwamukonda K, Lue T . The future is today: emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs. 2010; 15(3):467-80. PMC: 3163612. DOI: 10.1517/14728214.2010.480973. View

18.

Yao X, Luo T, Shi Y, He Z, Tang R, Zhang P . A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021; 31(8):836-846. PMC: 8208380. DOI: 10.1038/s41422-021-00523-8. View

19.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

20.

Ma X, Guan C, Chen R, Wang Y, Feng S, Wang R . Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients. Cell Mol Immunol. 2020; 18(2):487-489. PMC: 7734388. DOI: 10.1038/s41423-020-00604-5. View